# Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)

> **NCT02687594** · — · COMPLETED · sponsor: **Vifor Fresenius Medical Care Renal Pharma** · enrollment: 1400 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** sucroferric oxyhydroxide

## Key facts

- **NCT ID:** NCT02687594
- **Lead sponsor:** Vifor Fresenius Medical Care Renal Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-06
- **Primary completion:** 2019-04-06
- **Final completion:** 2019-04-06
- **Target enrollment:** 1400 (ACTUAL)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687594, "Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02687594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*